Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder
Sung-Wan Kim, Seetal Dodd, Lesley Berk, Jayashri Kulkarni, Anthony de Castella, Paul B. Fitzgerald, Jae-Min Kim, Jin-Sang Yoon, Michael Berk
Psychiatry Investig. 2015;12(3):349-355.   Published online 2015 Jul 6     DOI: https://doi.org/10.4306/pi.2015.12.3.349
Results from a randomized, double‐blind, placebo‐controlled, crossover, multimodal‐MRI pilot study of gabapentin for co‐occurring bipolar and cannabis use disorders
James J. Prisciandaro, William Mellick, Lindsay M. Squeglia, Sara Hix, Lauren Arnold, Bryan K. Tolliver
Addiction Biology.2022;[Epub]     CrossRef
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Lauren Kuhns, Emese Kroon, Karis Colyer-Patel, Janna Cousijn
Psychopharmacology.2022; 239(5): 1231.     CrossRef
Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study
Romain Icick, Ingrid Melle, Bruno Etain, Margrethe Collier Høegh, Sébastien Gard, Sofie R. Aminoff, Marion Leboyer, Ole A. Andreassen, Raoul Belzeaux, Chantal Henry, Thomas D. Bjella, Jean-Pierre Kahn, Nils Eiel Steen, Frank Bellivier, Trine Vik Lagerberg
Frontiers in Psychiatry.2022;[Epub]     CrossRef
An episode of mania following self‐reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report
Holly M. Hendin, Andrew D. Penn
Bipolar Disorders.2021; 23(7): 733.     CrossRef
Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential
Sabrina L. Botsford, Sharon Yang, Tony P. George
The American Journal on Addictions.2020; 29(1): 9.     CrossRef
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Eline Borger Rognli, Jørgen Gustav Bramness, Tilmann Soest
Acta Psychiatrica Scandinavica.2020; 141(2): 149.     CrossRef
Cannabis Use and the Risk for Psychosis and Affective Disorders
Lucia Sideli, Harriet Quigley, Caterina La Cascia, Robin M. Murray
Journal of Dual Diagnosis.2020; 16(1): 22.     CrossRef
Repercusiones del consumo de cannabis en la evolución del trastorno bipolar
Ruth Arias, Susana Alberich, Iñaki Zorrilla, Ana González-Pinto
Psiquiatría Biológica.2020; 27(2): 54.     CrossRef
Cannabis and mental illness: a review
Darby J. E. Lowe, Julia D. Sasiadek, Alexandria S. Coles, Tony P. George
European Archives of Psychiatry and Clinical Neuroscience.2019; 269(1): 107.     CrossRef
Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health?
Andrea H. Weinberger, Lauren R. Pacek, Christine E. Sheffer, Alan J. Budney, Joun Lee, Renee D. Goodwin
Drug and Alcohol Dependence.2019; 197: 134.     CrossRef
Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review
Sam Reid, Sagnik Bhattacharyya
Psychiatry Research.2019; 280: 112523.     CrossRef
Cannabis regulatory science: risk–benefit considerations for mental disorders
Jacob T. Borodovsky, Alan J. Budney
International Review of Psychiatry.2018; 30(3): 183.     CrossRef
Commentary on Ostergaard et al. (2017): Evidence of an association between cannabis use and suicide in subjects with bipolar disorder
Francesco Bartoli
Addiction.2017; 112(7): 1260.     CrossRef
Areas of controversy in neuroprogression in bipolar disorder
I. C. Passos, B. Mwangi, E. Vieta, M. Berk, F. Kapczinski
Acta Psychiatrica Scandinavica.2016; 134(2): 91.     CrossRef
Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder
Christina J. Hsieh, Douglass Godwin, Daniel Mamah
Frontiers in Psychiatry.2016;[Epub]     CrossRef